L Bujanda Selected Research

L Bujanda Research Topics

Disease

6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 10/2010
5	Neoplasms (Cancer) 01/2019 - 03/2014
4	Crohn Disease (Crohn's Disease) 01/2022 - 12/2016
4	Infections 05/2015 - 03/2002
3	Body Weight (Weight, Body) 09/2016 - 01/2012
3	Peptic Ulcer (Peptic Ulcers) 05/2015 - 08/2005
3	Colorectal Neoplasms (Colorectal Cancer) 03/2014 - 06/2006
2	Inflammation (Inflammations) 10/2019 - 03/2002
2	Liver Diseases (Liver Disease) 01/2018 - 10/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2014 - 08/2013
1	Ulcerative Colitis 01/2022
1	Fatty Liver 04/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Fatigue 08/2019
1	Polyps 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Biliary Atresia 01/2018
1	Cholangiocarcinoma 01/2018
1	Sclerosing Cholangitis 01/2018
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2018
1	Disease Progression 01/2017
1	Cysts 01/2017
1	Obesity 09/2016
1	Cardiomegaly (Heart Hypertrophy) 09/2016
1	Hyperinsulinism (Hyperinsulinemia) 09/2016
1	Hyperphagia (Overeating) 09/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Adenocarcinoma 03/2014
1	Hypercholesterolemia 06/2013
1	Insulin Resistance 06/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2013
1	Non-alcoholic Fatty Liver Disease 01/2012
1	Hemorrhage 03/2011
1	Angiodysplasia 03/2011
1	Diverticular Diseases 03/2011
1	Hepatitis B 10/2010
1	Liver Failure 10/2010
1	Esophageal Achalasia (Megaesophagus) 07/2010
1	Leukocytosis (Pleocytosis) 02/2010
1	Fever (Fevers) 02/2010
1	Ulcer 08/2005
1	Dyspepsia (Indigestion) 08/2005

Drug/Important Bio-Agent (IBA)

3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 10/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 01/2017
2	Infliximab (Remicade)FDA Link 01/2017 - 12/2016
2	LipidsIBA 09/2016 - 03/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 03/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2015 - 03/2011
2	AnticoagulantsIBA 03/2014 - 03/2011
2	Fluorouracil (Carac)FDA LinkGeneric 06/2013 - 06/2006
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	pterostilbeneIBA 04/2021
1	Triglycerides (Triacylglycerol)IBA 04/2021
1	FructoseIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CT-P13IBA 10/2019
1	SteroidsIBA 08/2019
1	Ustekinumab (CNTO 1275)FDA Link 01/2019
1	obeticholic acidIBA 01/2018
1	1-dodecylpyridoxal (PLD)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	6alpha-ethyl-23(S)-methylcholic acidIBA 01/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 12/2016
1	3,3',4,5'-tetrahydroxystilbeneIBA 09/2016
1	StilbenesIBA 09/2016
1	PolyphenolsIBA 09/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2016
1	ProdrugsIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 03/2014
1	Glycogen Synthase Kinase 3IBA 03/2014
1	Antineoplastic Agents (Antineoplastics)IBA 03/2014
1	Cyclin D3IBA 08/2013
1	Lovastatin (Mevacor)FDA LinkGeneric 06/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 06/2013
1	Atorvastatin (Lipitor)FDA Link 06/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2013
1	Fluvastatin FDA Link 06/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 06/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2013
1	Simvastatin (Zocor)FDA LinkGeneric 06/2013
1	ResveratrolIBA 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	2-mercaptopurineIBA 09/2011
1	TransferasesIBA 09/2011
1	Azathioprine (Imuran)FDA LinkGeneric 09/2011
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2010
1	RNA (Ribonucleic Acid)IBA 10/2010
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2010
1	Fibrinogen (Factor I)FDA Link 03/2002
1	Lipoproteins (Lipoprotein)IBA 03/2002

Therapy/Procedure

6	Therapeutics 08/2019 - 07/2001
2	Drug Therapy (Chemotherapy) 01/2016 - 06/2006
1	Colectomy 01/2019
1	Operative Surgical Procedures 01/2017
1	Retreatment 01/2017
1	Myotomy 07/2010
1	Adjuvant Chemotherapy 06/2006